Statement Of Cash Flows [Abstract]

Sopharma AD - Filing #6022425

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Income taxes paid, classified as operating activities
13 416 BGN
9 905 BGN
Income taxes refund, classified as operating activities
- BGN
49,000 BGN
Cash flows from (used in) investing activities [abstract]
Dividends received from associates, classified as investing activities
1 488 BGN
1 215 BGN
Proceeds from sales of interests in associates
2 845 BGN
- BGN
Purchase of interests in investments accounted for using equity method
27 933 BGN
16 480 BGN
Cash advances and loans made to related parties
5 689 BGN
13 500 BGN
Cash receipts from repayment of advances and loans made to related parties
19 039 BGN
684,000 BGN
Cash flows from (used in) financing activities [abstract]
Proceeds from non-current borrowings
36 565 BGN
2 163 BGN
Repayments of non-current borrowings
11 542 BGN
20 029 BGN
Proceeds from current borrowings
43 371 BGN
12,000 BGN
Repayments of current borrowings
1 187 BGN
59 072 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.